Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

67 results about "Chromosome regions" patented technology

Several chromosome regions have been defined by convenience in order to talk about gene loci. Most important is the distinction between chromosome region p and chromosome region q. These are virtual regions that exist in all chromosomes.

Probes, method and chip for detecting alpha and/or beta-thalassemia mutation based on whole-gene capture sequencing and application of such probes, such method and such chip

ActiveCN106591441AEnables detection of deletions in large regionsMicrobiological testing/measurementDNA/RNA fragmentationBeta thalassemiaNew mutation
The invention provides primers, a method and a chip for detecting alpha and/or beta-thalassemia point mutation and deletion mutation based on whole-gene capture sequencing and application of such primers, such method and such chip. The primers, the method, the chip and application thereof have the advantages that through designing of capture probes, relevant genes involved in alpha-thalassemia and beta-thalassemia are enriched and all mutation information including SNP and indel in full-length sequences of genes is detected; through addition of autosome, X-chromosome and Y-chromosome regions as well as upstream and downstream regions of coded genes as references, structure variations such as SNV and CNV are detected; compared with existing various hotspot mutation site detection technologies, the method is capable of detecting hotspot mutation information as well as some rare mutations and undiscovered new mutation types to detect and analyze full-length sequence specificity of target genes, fully covers the mutation types and makes up the defect that a conventional detection method easily causes missing detection of low-frequency mutations and rare mutations greatly.
Owner:SHENZHEN E GENE TECH

Method for randomly knocking out streptomyces genome DNA large fragment in vivo

The invention discloses a method for randomly knocking out a streptomyces genome DNA large fragment in vivo. The method comprises the following steps: (1) constructing series of recombinant plasmids pTNL_101, pTNL_103, pTNL_104 and pTNL_105 as a first sceS enzyme cutting site random introduced plasmid; (2) introducing the constructed recombinant plasmids pTNL_101, pTNL_103, pTNL_104 and pTNL_105 into streptomyces coelicolor M145, and constructing a mutant sub-library 1 without random chromosome large fragment; (3) constructing the series of recombinant plasmids pTNL_102 as a second sceS enzyme cutting site random introduced plasmid, and introducing into the mutant sub-library 1 to obtain a mutant sub-library 2; (4) screening out large fragment knockout muton by using an R2YE flat panel, precisely positioning a chromosome deletion region segment, and performing positioning knockout in an original strain to perform verification. The method disclosed by the invention can be used for removing removable parts of a chromosome region effectively and randomly; at present, a positioning result shows that the lengths of the knockout fragments are between 2kb and 100kb, thus an evidence for transforming streptomyces into antibiotic heterologous expression hosts and chassis organisms can be provided.
Owner:NANTONG UNIVERSITY

Kit and method for detecting chromosome heterozygosity loss on basis of amplicon sequencing

The invention discloses a kit and method for detecting chromosome heterozygosity loss on the basis of amplicon sequencing, belongs to the field of molecular biology nucleic acid detection, and relatesto the kit and method for detecting chromosome heterozygosity loss by means of amplicon sequencing. The kit contains a mixture of 14 groups of primer pairs used for detecting a 1p36.32 region of a human chromosome 1, 6 groups of primer pairs used for detecting a 1q25.2 region of the human chromosome 1, 14 groups of primer pairs used for detecting a 19p13.2 region of a human chromosome 19 and 7 groups of primer pairs used for detecting a 19q13.33 region of the human chromosome 19, 20 kinds of tag primers used for distinguishing samples, a GC stabilizer, a PCR enzyme mixture, purifying magneticbeads, a quality control standard substance and ddH2O. Through two-time PCR amplification and two-time product purification and sequencing, through a ratio of READS(1p) / READS(1q) to READS(19q) / READS(19p), the heterozygosity loss state of 1p19q in the samples is analyzed. By adopting the method, the variation situation of the 1p19q can be reflected comprehensively, truly and accurately, and gene variation of the 96 samples can be subjected to high-throughput detection and analysis simultaneously, so that the detection cost is greatly reduced.
Owner:艾普拜生物科技(苏州)有限公司

Optimizing genome-wide mutation analysis of chromosomes and genes

A method of genome-wide testing of gene copy number at the genetically most important loci to determine whether the gene and/or its selected larger surrounding chromosome region is rearranged to result in an unbalanced abnormality in one or more subjects, said method including selecting multiple gene loci of said DNAs to be examined in said test, conducting said test, and comparing the number of copies at each locus tested by quantification of total gene target number to determine the relative, number of each polymorphic sequence detected to assure that each important tested sequence is distinguished from the other alleles at the same locus. A method of detecting the highest number of abnormal patients possible based upon the number of test sites available in a protocol including selecting the most common genetic disease-causing mutations in a population by frequency, selecting and identifying the most common mutations in each by frequencies, multiplying the two frequencies together to get a frequency product which is the frequency of each mutation in the population, and ordering the frequency products beginning with the most common to prioritize which are the most common to detect the largest number of genetic abnormalities possible per test. Depending upon the stage of the life cycle, both of the methods can be done together or in sequence.
Owner:CHILDRENS HOSPITAL MEDICAL CENT OF AKRON

Optimizing genome-wide mutation analysis of chromosomes and genes

A method of genome-wide testing of gene copy number at the genetically most important loci to determine whether the gene and / or its selected larger surrounding chromosome region is rearranged to result in an unbalanced abnormality in one or more subjects, said method including selecting multiple gene loci of said DNAs to be examined in said test, conducting said test, and comparing the number of copies at each locus tested. by quantification of total gene target number to determine the relative number of each polymorphic sequence detected to assure that each important tested sequence is distinguished from the other alleles at the same locus. A method of detecting the highest number of abnormal patients possible based upon the number of test sites available in a protocol including selecting the most common genetic disease-causing mutations in a population by frequency, selecting and identifying the most common mutations in each by frequencies, multiplying the two frequencies together to get a frequency product which is the frequency of each mutation in the population, and ordering the frequency products beginning with the most common to prioritize which are the most common to detect the largest number of genetic abnormalities possible per test. Depending upon the stage of the life cycle, both of the methods can be done together or in sequence.
Owner:CHILDRENS HOSPITAL MEDICAL CENT OF AKRON
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products